GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (FRA:2LQ) » Definitions » Cyclically Adjusted Price-to-FCF

Elixxer (FRA:2LQ) Cyclically Adjusted Price-to-FCF : (As of Jun. 19, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Elixxer Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Elixxer Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Elixxer's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Cyclically Adjusted Price-to-FCF Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Elixxer's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Elixxer's Cyclically Adjusted Price-to-FCF falls into.



Elixxer Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Elixxer's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Elixxer's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.002/125.2304*125.2304
=-0.002

Current CPI (Sep. 2023) = 125.2304.

Elixxer Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201306 0.177 97.182 0.228
201309 -0.043 97.419 -0.055
201312 -0.067 96.945 -0.087
201403 -0.072 98.604 -0.091
201406 -0.425 99.473 -0.535
201409 -0.150 99.394 -0.189
201412 -0.115 98.367 -0.146
201503 -0.108 99.789 -0.136
201506 -0.159 100.500 -0.198
201509 -0.047 100.421 -0.059
201512 -0.091 99.947 -0.114
201603 -0.063 101.054 -0.078
201606 -0.197 102.002 -0.242
201609 0.000 101.765 0.000
201612 -0.147 101.449 -0.181
201703 -0.163 102.634 -0.199
201706 -0.068 103.029 -0.083
201709 -0.395 103.345 -0.479
201712 -0.277 103.345 -0.336
201803 -0.170 105.004 -0.203
201806 -0.264 105.557 -0.313
201809 -0.223 105.636 -0.264
201812 -0.259 105.399 -0.308
201903 -0.280 106.979 -0.328
201906 -0.215 107.690 -0.250
202003 -0.101 107.927 -0.117
202006 0.027 108.401 0.031
202009 -0.117 108.164 -0.135
202012 -0.138 108.559 -0.159
202103 -0.119 110.298 -0.135
202106 -0.073 111.720 -0.082
202109 -0.049 112.905 -0.054
202112 -0.085 113.774 -0.094
202203 -0.025 117.646 -0.027
202206 -0.116 120.806 -0.120
202209 -0.057 120.648 -0.059
202212 -0.003 120.964 -0.003
202303 -0.097 122.702 -0.099
202306 -0.040 124.203 -0.040
202309 -0.002 125.230 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Elixxer  (FRA:2LQ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Elixxer Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Elixxer's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (FRA:2LQ) Business Description

Industry
Traded in Other Exchanges
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (FRA:2LQ) Headlines

No Headlines